PICC catheter for hematologic tumor patient
By inserting metal wires into the PICC catheter and combining them with ultrasonic transducers, non-invasive ultrasound treatment is provided, which solves the safety and efficiency of thrombosis and blockage treatment in traditional methods, achieving more efficient and safer treatment effects , reduces costs and inconvenience to patients, and provides long-term monitoring and preventive measures.
Patent Information
- Application Number
- CN202411269927.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-11
- Publication Date
- 2024-11-08
AI Technical Summary
When dealing with thrombosis and blockage problems in PICC catheters, the prior art has problems such as low safety, low efficiency, inconvenience to patients and high cost. Especially the traditional ultrasonic removal method has great harm to the human body and poor effect. Invasive method The treatment of central venous catheters is not specialized and has high risk.
Designed a PICC catheter system combining ultrasonic technology and innovative catheter design, which provides non-invasive, continuous treatment, reducing surgical intervention and infection risk by embedding wires in the catheter and combining with ultrasonic transducers. cost, improve treatment adaptability and efficiency.
Achieve safer and more efficient thrombosis and clogging treatments, reduce physical harm and medical costs to patients, simplify treatment operations, improve treatment adaptability and patient comfort, reduce the risk of thrombosis, and provide Measures to monitor and prevent complications for a long time.
Smart Images

Figure CN118903643A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of medical equipment, and in particular relates to a PICC catheter for patients with blood tumors. Background Art
[0002] In patients who are treated for hematologic malignancies or undergo long-term intravenous infusions, percutaneous central venous catheters (PICCs) are often used to provide a long-term and stable route for drug administration. Although PICC lines provide great convenience for treatment, their use often encounters problems such as catheter blockage and thrombosis. Catheter blockage may not only lead to treatment interruption, but also cause serious medical complications such as infection and thromboembolism.
[0003] Traditionally, approaches to addressing these issues have included the use of thrombolytic agents, mechanical removal devices, or catheter replacement. However, each of these approaches has limitations:
[0004] Thrombolytics may cause side effects such as bleeding, especially in patients with hematological malignancies, whose bleeding risk is already high.
[0005] Mechanical removal methods may cause damage to the vessel wall and increase the risk of infection.
[0006] Catheter replacement is a more costly approach with additional inconvenience for the patient.
[0007] Therefore, there is an urgent need to develop a safe, effective and convenient new technology to solve the problems of thrombosis and blockage during the use of PICC catheters.
[0008] Among the existing patent application technologies, there are also methods of using ultrasound to remove thrombi, one is to remove from outside the body, and the other is to remove by invading blood vessels;
[0009] As for the method of removing blood clots from the body, high-frequency ultrasound has low penetrating power and is difficult to penetrate the flesh and blood directly to the blood vessels. Although low-frequency ultrasound has strong penetrating power, it is not effective in removing blood clots after the flesh and blood are consumed. In general, it is more harmful to the human body and has a poor effect.
[0010] Regarding the method of clearing invaded blood vessels, firstly, there is no existing technology specifically for thrombosis or blockage caused by central venous catheters. If it is necessary to deal with thrombosis or blockage caused by central venous catheters, the central venous catheter must be removed first, and then a special device is inserted into the blood vessel to clear the thrombus, and finally the central venous catheter must be reinserted; this is very harmful to the patient and the risk is very high. Summary of the invention
[0011] The purpose of the present invention is to provide a PICC catheter for patients with blood tumors. The PICC catheter system of the present invention combines ultrasonic technology and innovative catheter design to improve the safety, efficiency and patient comfort of thrombus and blockage treatment, while also achieving effective cost control and simplification of treatment operations, providing a more ideal medical solution for patients with long-term intravenous infusion.
[0012] The technical solution adopted by the present invention is as follows:
[0013] A PICC catheter for patients with hematological tumors, wherein one end of the catheter 1 is inserted into a vein 6, and the outer end is provided with a connector 5 for connecting an infusion pump or a syringe; a plurality of convex strips 2 extending in a straight direction of the catheter 1 are evenly arranged on the outer circumference of the catheter 1; a metal wire 3 is embedded in the convex strip 2 along its length direction; the rear end of the metal wire 3 located outside the body can be subjected to ultrasonic vibration through an ultrasonic transducer 4.
[0014] Wherein, the cross section of the metal wire 3 is semicircular.
[0015] Wherein, the metal wire 3 is a titanium alloy filament.
[0016] Wherein, the diameter of the metal wire 3 is 0.1-0.5 mm.
[0017] The convex strip 2 and the conduit 1 are integrally formed.
[0018] The material of the convex strip 2 and the conduit 1 is polyurethane or silicone.
[0019] The outer diameter of the catheter 1 is 1.5-3 mm, and the inner diameter is 1-2.5 mm.
[0020] The convex strip 2 is a circular arc convexity with a height of 0.5 to 1 mm.
[0021] Wherein, the number of the convex strips 2 is 3 to 6.
[0022] The ultrasonic transducer 4 is configured to generate ultrasonic vibrations in a frequency range of 20 kHz to 3 MHz; the power is set at 0.1 to 3 Watts / cm 2 ; The amplitude is at the micron level; The application time is intermittent, and each application lasts from a few seconds to a few minutes; The duty cycle is set between 20% and 50%.
[0023] In summary, due to the adoption of the above technical solution, the beneficial effects of the present invention are:
[0024] 1. Compared with the existing ultrasonic thrombus removal methods and traditional thrombus and catheter blockage treatment methods, the PICC catheter system of the present invention provides a number of significant advantages:
[0025] Optimal combination of non-invasive and continuous treatment
[0026] In the present invention, the ultrasonic transducer is integrated with the catheter, allowing ultrasonic energy to be directly transmitted to the location of the thrombus or blockage through the metal wire embedded in the catheter. This design avoids the operation of inserting the device into the blood vessel required for traditional invasive ultrasonic treatment, reducing physical harm to the patient and related risks. In addition, compared with extracorporeal ultrasound, this method can more accurately apply ultrasound locally, improving the effectiveness and safety of treatment.
[0027] Reduce surgical intervention and associated risks
[0028] Since the ultrasonic device is directly integrated with the PICC catheter, the present invention does not require the removal or reinsertion of the catheter when treating thrombosis. This not only alleviates the pain and inconvenience of the patient, but also significantly reduces the risk of infection and vascular damage that may be caused by repeated manipulation of the catheter.
[0029] Cost efficiency and ease of operation
[0030] Compared with traditional mechanical removal and catheter replacement methods, the ultrasonic treatment scheme of the present invention reduces the reliance on high-cost medical consumables and reduces the technical requirements of medical professionals during operation. The ultrasonic equipment is simple to use and can be operated by ordinary medical staff after receiving basic training, which greatly reduces the overall cost and complexity of treatment.
[0031] Improve the adaptability and efficiency of treatment
[0032] The present invention allows personalized treatment according to the specific conditions of different patients and the nature of thrombus by adjusting the parameters such as the frequency, power, vibration amplitude and application time of ultrasound. This flexibility ensures that the treatment can be optimized in a targeted manner to obtain the best therapeutic effect.
[0033] Long-term monitoring and prevention of complications
[0034] By integrating ultrasound function into the catheter, the present invention can not only provide immediate interventional treatment at the early stage of thrombosis, but also monitor the patient's vascular status and prevent the re-formation of thrombosis through regular ultrasound application as a preventive measure.
[0035] In summary, the PICC catheter system of the present invention combines ultrasonic technology and innovative catheter design to improve the safety, efficiency and patient comfort of thrombosis and blockage treatment, while also achieving effective cost control and simplification of treatment operations, providing a more ideal medical solution for patients with long-term intravenous infusion.
[0036] 2. The present invention uses a metal wire with a semicircular cross-section, which not only makes the connection between the convex strip and the catheter smoother, thereby providing a streamlined structure, which helps to reduce the resistance of blood passing through the catheter. Reducing internal resistance not only helps to maintain a better hemodynamic state, but also helps to reduce the retention of blood in the catheter, thereby reducing the risk of thrombosis. Secondly, due to the structural characteristics of the semicircular cross-section, the propagation of ultrasound in the metal wire shows different focusing effects, so that the ultrasonic vibration received by the thrombus or blockage is more chaotic, thereby improving the crushing effect and efficiency of the thrombus or blockage.
[0037] 3. The boss structure of the present invention can change the flow characteristics of blood in the catheter. The tiny gaps and concave-convex surfaces formed by these structures help reduce the laminar flow characteristics of blood and promote the formation of more eddies in the blood. Such eddies can increase the flow rate of blood and reduce the time that blood stays in the catheter, thereby effectively reducing the formation of thrombus. At the same time, the convex strips prevent blood from being retained in a certain part of the catheter by breaking the uniformity of blood flow. Retention is one of the main causes of thrombosis.
[0038] At the same time, the close fit between the catheter and the vessel wall may lead to continuous physical stimulation of the inner wall of the vessel, which may trigger an inflammatory response or damage, thereby increasing the risk of thrombosis. The ribs reduce this direct contact by creating tiny gaps between the catheter and the vessel wall, reducing irritation and related complications. These gaps not only prevent the catheter from clinging to the vessel wall, but also allow blood to flow around the catheter, promoting better blood circulation and exchange of nutrients.
[0039] In addition, the ribs increase the overall structural strength of the catheter, making it more durable and reducing the risk of damage due to bending or twisting. At the same time, this structural design also maintains a certain flexibility of the catheter, making it easier to operate and place, especially when it needs to cross complex vascular pathways.
[0040] When ultrasound is used for thrombolysis, the convex strips can help distribute the ultrasound energy more evenly, ensuring that the energy is effectively delivered to the target area, thereby improving the effectiveness and efficiency of the treatment.
[0041] 4. The present invention combines ultrasound with PLCC catheters to bring unexpected effects:
[0042] Enhances the structural integrity of the catheter
[0043] Stretching effect: Ultrasonic vibration is evenly distributed throughout the catheter through the metal wire. Not only does the metal wire not affect the flexibility of the catheter too much because it is very thin, but it can also effectively keep the catheter in an expanded state. This "stretching" effect helps prevent the catheter from naturally shrinking or bending when it is not under stress, thereby maintaining its ideal physical shape.
[0044] Prevents catheter kinks and bends
[0045] Dynamic adjustment: During daily activities or medical procedures, especially during strenuous exercise, the catheter may be bent or knotted due to external forces. During ultrasound treatment, the catheter can be re-stretched to ensure that the catheter's openness and function are not affected, such as blood flow obstruction caused by breakage or local compression, increasing the safety of treatment.
[0046] Improve catheter handling and patient comfort
[0047] Ultrasonic vibration can also be performed synchronously during the catheter insertion process. In this way, the continuous action of ultrasonic vibration can also enhance the flexibility of the catheter, making it easier to pass through complex vascular pathways and reducing friction and damage to the inner wall of the blood vessel.
[0048] Optimize the efficiency of ultrasonic energy application
[0049] Uniform energy distribution: Ultrasonic energy is evenly transmitted through the metal wire, which not only improves the local efficiency of ultrasound in thrombus treatment, but also makes the entire catheter subject to uniform energy, which helps to prevent local tissue damage that may be caused by energy concentration points. BRIEF DESCRIPTION OF THE DRAWINGS
[0050] Figure 1 It is a schematic diagram of an axial cross section of the PICC catheter of the present invention in a blood vessel;
[0051] Figure 2 It is a radial cross-sectional schematic diagram of the PICC catheter of the present invention;
[0052] Figure 3 It is a schematic diagram of the metal wire of the PICC catheter of the present invention being connected to the ultrasonic transducer.
[0053] Markings in the figure: 1. Catheter; 2. Raised strip; 3. Metal wire; 4. Ultrasonic transducer; 5. Connector; 6. Vein; 7. Thrombus. DETAILED DESCRIPTION
[0054] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0055] See also Figures 1 to 3 The present invention relates to a PICC catheter for patients with blood tumors, wherein one end of the catheter 1 is inserted into a vein 6, and the outer end is provided with a connector 5 for connecting an infusion pump or a syringe; a plurality of convex strips 2 extending in a straight direction of the catheter 1 are evenly arranged on the outer circumference of the catheter 1; a metal wire 3 is embedded in the convex strip 2 along its length direction; the rear end of the metal wire 3 located outside the body can be subjected to ultrasonic vibration through an ultrasonic transducer 4.
[0056] Furthermore, the cross section of the metal wire 3 is semicircular.
[0057] Furthermore, the metal wire 3 is a titanium alloy filament. Titanium and its alloys are very common in medicine, especially in orthopedic implants and pacemakers. Titanium has very good biocompatibility and is almost not rejected by human tissue. Titanium alloy has excellent mechanical properties and corrosion resistance, as well as good ductility, and can be processed into filaments for medical sutures or other biomedical applications.
[0058] Furthermore, the diameter of the metal wire 3 is 0.1-0.5 mm.
[0059] Furthermore, the convex strip 2 and the conduit 1 are integrally formed.
[0060] Furthermore, the material of the convex strip 2 and the conduit 1 is polyurethane or silicone.
[0061] Furthermore, the outer diameter of the catheter 1 is 1.5 to 3 mm, and the inner diameter is 1 to 2.5 mm, and such size is sufficient to meet most infusion and injection requirements.
[0062] Furthermore, the convex strip 2 is a circular arc protrusion with a height of 0.5 to 1 mm, which will not cause excessive pressure on the mirror blood vessel 6.
[0063] Furthermore, the number of the convex strips 2 is 3 to 6.
[0064] Furthermore, in order to effectively use ultrasonic vibration to treat the metal wire in the PICC catheter to prevent thrombosis 7 and promote blood flow, a series of ultrasonic parameters need to be considered, including frequency, power, vibration amplitude, application time, and periodicity of vibration.
[0065] frequency
[0066] The frequency of ultrasound waves is usually between 20 kHz and 10 MHz. For medical use, especially for applications to reduce thrombus 7 formation, low to medium frequencies (about 20 kHz to 3 MHz) are used.
[0067] Lower frequencies can effectively transfer energy and promote blood flow without damaging the inner wall of the vein 6.
[0068] power
[0069] The power selection should be based on the specific needs of the application and should be adjusted according to the characteristics of the wire and the location of the catheter. The range is 0.1 to 3 Watts / cm 2 to ensure adequate energy delivery while avoiding overheating or other potential tissue damage.
[0070] Vibration Amplitude
[0071] The vibration amplitude is usually in the micron level, and the appropriate vibration amplitude helps to effectively transmit the vibration energy to the blood flow without causing tissue damage.
[0072] Application time
[0073] Ultrasound waves can be applied continuously or intermittently. Treatments can last from a few seconds to several minutes.
[0074] The length of application time depends on the specific clinical needs and the patient's condition. Intermittent application can reduce thermal effects and improve safety.
[0075] Periodicity
[0076] Duty cycle refers to the ratio of ultrasonic on time to total time, usually expressed as a percentage.
[0077] A lower duty cycle (eg, 20% to 50%) helps reduce heat accumulation and is suitable for prolonged ultrasound treatments.
[0078] The working method of the present invention is:
[0079] 1. PICC catheter insertion method:
[0080] Before the catheter is inserted, the patient's skin is first disinfected and a local anesthetic is applied to reduce patient discomfort.
[0081] Using standard aseptic techniques, the PICC catheter is introduced into the central vein through venous puncture in the upper arm. X-rays are used to ensure the correct position of the catheter. During this process, the metal wire embedded in the convex strip 2 can be used as a basis for judging the insertion position of the catheter under X-rays.
[0082] 2. Regularly perform ultrasonic vibration to clear PICC catheter blockage and prevent peripheral thrombosis 7 methods:
[0083] Preparation
[0084] Clinical evaluation: Before starting ultrasound treatment, a comprehensive clinical evaluation of the patient should be performed, including assessment of the patient's hemodynamic status and functionality of the PICC catheter. Confirm that there are no immediate surgical or medical contraindications, such as severe bleeding tendency or local infection of the catheter.
[0085] Catheter inspection: Check the integrity and position of the PICC catheter. Use appropriate imaging techniques (such as X-ray or ultrasound imaging) to confirm that the catheter is correctly positioned and not displaced, and initially assess whether there is obvious blockage or thrombosis7.
[0086] Equipment preparation: Prepare the ultrasonic equipment and set the appropriate frequency and power. Ensure all equipment is calibrated and sterilized.
[0087] Ultrasound therapy settings
[0088] Frequency selection: Set the ultrasound frequency between 20kHz and 3MHz, and select the frequency that has the best therapeutic effect on blood and thrombus7.
[0089] Power adjustment: Set the power between 0.1 and 3 Watts / cm according to the initial assessment of the catheter and thrombus 7 2 to ensure that the thrombus 7 can be penetrated without damaging the wall of the venous vessel 6.
[0090] Vibration amplitude and periodicity: The vibration amplitude is set at the micron level, and the duty cycle is set at 20% to 50%, which is adjusted in time according to the treatment response to optimize the thrombus removal efficiency and reduce thermal effects.
[0091] Ultrasound therapy implementation
[0092] Apply ultrasound: Under the supervision of medical staff, gradually start the ultrasound device, starting from low power and slowly increasing to the predetermined power. Continue to observe the patient's physiological response and comfort.
[0093] Treatment time: The treatment time can be adjusted according to the size and hardness of the thrombus 7, generally ranging from a few minutes to 30 minutes. Depending on the treatment effect and patient response, the treatment can be carried out in multiple sessions.
[0094] Real-time monitoring: Use ultrasound or other imaging techniques to monitor changes in thrombi and blockages in real time. Ensure that ultrasound is applied correctly to the target area and observe whether the thrombus is broken down or moved.
[0095] Follow-up monitoring and evaluation
[0096] Short-term evaluation: Immediately after treatment, the patient is clinically evaluated, including checking the function of the PICC line and ensuring there are no new complications such as bleeding or infection.
[0097] Long-term follow-up: Schedule regular follow-up visits to continue monitoring the status of the catheter and the patient's overall health. Repeat ultrasound treatments as needed.
[0098] Safety measures
[0099] Patient education: Explain the treatment process, expected effects and possible side effects to the patient in detail, and obtain the patient's informed consent.
[0100] Emergency Preparedness: Be prepared for possible acute reactions, such as anaphylaxis or hemodynamic instability, and ensure that appropriate medical support and equipment are available on site.
[0101] This detailed protocol maximizes the safety and effectiveness of ultrasound therapy in clearing PICC catheter obstruction and preventing peripheral thrombosis.
[0102] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A PICC catheter for patients with hematological tumors, wherein one end of the catheter (1) is inserted into a vein (6), and the outer end is provided with a connector (5) for connecting an infusion pump or a syringe; characterized in that: The outer circumference of the catheter (1) is evenly provided with a plurality of convex strips (2) extending in a straight direction of the catheter (1); a metal wire (3) is embedded in the convex strip (2) along its length direction; and the rear end of the metal wire (3) located outside the body can be subjected to ultrasonic vibration through an ultrasonic transducer (4).
2. A PICC catheter for patients with blood tumors as claimed in claim 1, characterized in that: The cross section of the metal wire (3) is semicircular.
3. A PICC catheter for patients with blood tumors as claimed in claim 2, characterized in that: The metal wire (3) is a titanium alloy filament.
4. A PICC catheter for patients with blood tumors as claimed in claim 3, characterized in that: The diameter of the metal wire (3) is 0.1-0.5 mm.
5. The PICC catheter for patients with hematological tumors according to claim 1, characterized in that: The convex strip (2) and the conduit (1) are integrally formed.
6. A PICC catheter for patients with blood tumors as claimed in claim 1, characterized in that: The material of the convex strip (2) and the conduit (1) is polyurethane or silicone.
7. The PICC catheter for patients with hematological tumors according to claim 1, characterized in that: The outer diameter of the catheter (1) is 1.5 to 3 mm, and the inner diameter is 1 to 2.5 mm.
8. The PICC catheter for patients with hematological tumors according to claim 1, characterized in that: The convex strip (2) is a circular arc convexity with a height of 0.5 to 1 mm.
9. The PICC catheter for patients with hematological tumors according to claim 1, characterized in that: The number of the convex strips (2) is 3 to 6.
10. The PICC catheter for patients with hematological tumors according to claim 1, characterized in that: The ultrasonic transducer (4) is configured to generate ultrasonic vibrations in a frequency range of 20 kHz to 3 MHz. Power setting from 0.1 to 3 Watts / cm 2 ; The amplitude is at the micron level; the application time is intermittent, Each application lasts from a few seconds to a few minutes; the duty cycle is set between 20% and 50%.
Citation Information
Patent Citations
Enhanced tracheal cannula
CN200987823Y
Ultrasound enhanced central venous catheter
US20050197619A1
